Cargando…
Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
BACKGROUND: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...
Autores principales: | Scott, Nick, Win, Thin Mar, Tidhar, Tom, Htay, Hla, Draper, Bridget, Aung, Phyo Thu Zar, Xiao, Yinzong, Bowring, Anna, Kuschel, Christian, Shilton, Sonjelle, Kyi, Khin Pyone, Naing, Win, Aung, Khin Sanda, Hellard, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315611/ https://www.ncbi.nlm.nih.gov/pubmed/34327345 http://dx.doi.org/10.1016/j.lanwpc.2021.100129 |
Ejemplares similares
-
Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
por: Draper, Bridget Louise, et al.
Publicado: (2020) -
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
por: Draper, Bridget Louise, et al.
Publicado: (2022) -
Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
por: Win, Thin Mar, et al.
Publicado: (2023) -
Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar
por: Draper, Bridget Louise, et al.
Publicado: (2021) -
Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study
por: Yee, Win Lei, et al.
Publicado: (2023)